BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38021664)

  • 1. Distinguishing Fibroepithelial Lesions Requires Clinical, Imaging, and Pathology Correlation.
    Bradley M; Miles B; Young P; He J; Nguyen QD
    Cureus; 2023 Oct; 15(10):e47673. PubMed ID: 38021664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
    Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
    Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phyllodes tumors and fibroadenoma common beginning and different ending.
    Oprić S; Oprić D; Gugić D; Granić M
    Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
    Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
    Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
    Resetkova E; Khazai L; Albarracin CT; Arribas E
    Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism.
    Wu Y; Wang Y; He C; Wang Y; Ma J; Lin Y; Zhou L; Xu S; Ye Y; Yin W; Ye J; Lu J
    Anal Chim Acta; 2023 Dec; 1283():341897. PubMed ID: 37977771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins.
    Cowan ML; Argani P; Cimino-Mathews A
    Mod Pathol; 2016 Mar; 29(3):259-65. PubMed ID: 26743469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy.
    Wiratkapun C; Piyapan P; Lertsithichai P; Larbcharoensub N
    Diagn Interv Radiol; 2014; 20(1):27-33. PubMed ID: 24356293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
    Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
    Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
    Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
    Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroepithelial Lesion Initially Believed to Be Fibroadenoma, but Interval Growth Consistent With Phyllodes Tumor.
    Nguyen QD; Krider SO; Roberts JT; Posleman Monetto FE; He J
    Cureus; 2020 Sep; 12(9):e10363. PubMed ID: 33062486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Texture Analysis of Ultrasound Images to Differentiate Simple Fibroadenomas From Complex Fibroadenomas and Benign Phyllodes Tumors.
    Basara Akin I; Ozgul H; Simsek K; Altay C; Secil M; Balci P
    J Ultrasound Med; 2020 Oct; 39(10):1993-2003. PubMed ID: 32329531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.
    Seow DYB; Tay TKY; Tan PH
    Semin Diagn Pathol; 2022 Sep; 39(5):333-343. PubMed ID: 35523613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroepithelial tumours of the breast-a review.
    Lerwill MF; Lee AHS; Tan PH
    Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent giant fibroadenomas with transformation to cystosarcoma phyllodes in a 17-year-old girl: a rare case report from Syria.
    Ismail S; Alaidi S; Jouni S; Kassab Y; Al-Shehabi Z
    J Med Case Rep; 2019 Dec; 13(1):378. PubMed ID: 31862014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
    Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways.
    Pareja F; Geyer FC; Kumar R; Selenica P; Piscuoglio S; Ng CKY; Burke KA; Edelweiss M; Murray MP; Brogi E; Weigelt B; Reis-Filho JS
    NPJ Breast Cancer; 2017; 3():40. PubMed ID: 29043292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Phyllodes Tumor of the Breast and Pregnancy: A Rare Case Report and Literature Review.
    Mustață L; Gică N; Botezatu R; Chirculescu R; Gică C; Peltecu G; Panaitescu AM
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
    Chang J; Denham L; Dong EK; Malek K; Lum SS
    Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.